DexCom (DXCM) Tops Q2 EPS by 5c, Names CFO

DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.16), $0.05 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $170.6 million versus the consensus estimate of $166.3 million.

DexCom Appoints New CFO

In conjunction with its earnings release, DexCom announced that Quentin Blackford has been appointed Chief Financial Officer, expected to occur on September 1, 2017. Mr. Blackford most recently served as Executive Vice President and Chief Financial Officer, Head of Strategy and Corporate Integrity at NuVasive, where he played a key role through a phase of significant growth and improvements in profitability since 2009. Prior to NuVasive, he was employed at Zimmer Holdings, Inc., serving most recently as Director of Finance and Controller of the Dental Division. Mr. Blackford obtained his Certified Public Accounting license (currently inactive) after receiving dual Bachelor of Science degrees in Accounting and Business Administration from Grace College

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• NVE Corporation names new CEO and expands board to seven members